Reuters logo
BRIEF-Kee Song Bio-Technology Holdings adjusts conversion price of 1st series domestic unsecured convertible corporate bonds to T$36.12
July 12, 2017 / 10:05 AM / 4 months ago

BRIEF-Kee Song Bio-Technology Holdings adjusts conversion price of 1st series domestic unsecured convertible corporate bonds to T$36.12

July 12 (Reuters) - Kee Song Bio-Technology Holdings Ltd :

* Says it adjusts conversion price of 1st series domestic unsecured convertible corporate bonds to T$36.12, effective Aug. 2

Source text in Chinese: goo.gl/AMsJ2s

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below